nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Autologous Stem Cell Transplantation in Central Nervous System Lymphoma: A Multicenter Retrospective Series and a Review of the Literature
|
Dholaria, Bhagirathbhai R. |
|
2019 |
19 |
6 |
p. e273-e280 |
artikel |
2 |
Checking in on Lenalidomide in Diffuse Large B Cell Lymphoma
|
Goldfinger, Mendel |
|
2019 |
19 |
6 |
p. e307-e311 |
artikel |
3 |
Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients
|
El Gammal, Mosaad M. |
|
2019 |
19 |
6 |
p. e281-e290 |
artikel |
4 |
Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|
Jeon, Young-Woo |
|
2019 |
19 |
6 |
p. 345-355.e7 |
artikel |
5 |
Clinical Predictors and Prognostic Model for Pediatric Lymphoblastic Lymphoma Treated With Uniform BFM90 Protocol: A Single-Center Experience of 65 Patients From Asia
|
Patel, Amol |
|
2019 |
19 |
6 |
p. e291-e298 |
artikel |
6 |
Correlations Between Imaging Biomarkers and Proliferation Index Ki-67 in Lymphomas: A Systematic Review and Meta-Analysis
|
Meyer, Hans-Jonas |
|
2019 |
19 |
6 |
p. e266-e272 |
artikel |
7 |
Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes
|
Andraos, Therese |
|
2019 |
19 |
6 |
p. 381-389 |
artikel |
8 |
Editorial Board
|
|
|
2019 |
19 |
6 |
p. A5-A6 |
artikel |
9 |
Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Aplasia After Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
|
Vydra, Jan |
|
2019 |
19 |
6 |
p. 365-371 |
artikel |
10 |
Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient
|
Ghobrial, Irene |
|
2019 |
19 |
6 |
p. 332-344 |
artikel |
11 |
Impact of Additional Cytogenetic Abnormalities on the Clinical Behavior of Patients With Chronic Myeloid Leukemia: Report on a Latin American Population
|
Morales-Chacón, Katherinee |
|
2019 |
19 |
6 |
p. e299-e306 |
artikel |
12 |
Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma
|
Jagannath, Sundar |
|
2019 |
19 |
6 |
p. 372-380 |
artikel |
13 |
Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma
|
Ureshino, Hiroshi |
|
2019 |
19 |
6 |
p. 326-331 |
artikel |
14 |
Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience
|
Cooper, Jason P. |
|
2019 |
19 |
6 |
p. 390-395 |
artikel |
15 |
Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma
|
Barta, Stefan K. |
|
2019 |
19 |
6 |
p. 356-364.e3 |
artikel |
16 |
Racial and Socioeconomic Disparities in Mantle Cell Lymphoma
|
Shah, Nikesh N. |
|
2019 |
19 |
6 |
p. e312-e320 |
artikel |
17 |
Role of p15(INK4B) Methylation in Patients With Myelodysplastic Syndromes: A Systematic Meta-Analysis
|
Ye, Fang |
|
2019 |
19 |
6 |
p. e259-e265 |
artikel |
18 |
SOHO State of the Art Updates and Next Questions: The Conundrum in Assessing the Therapy Response of Patients With Chronic Lymphocytic Leukemia
|
Choi, Michael Y. |
|
2019 |
19 |
6 |
p. 321-325 |
artikel |
19 |
Table of Contents
|
|
|
2019 |
19 |
6 |
p. A7, A13-A15 |
artikel |
20 |
Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With Alectinib
|
Reed, Daniel R. |
|
2019 |
19 |
6 |
p. e247-e250 |
artikel |
21 |
When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds
|
Gilmore, Brendan A. |
|
2019 |
19 |
6 |
p. e251-e258 |
artikel |